Home LiteratureArticle Details
PMID: 85994 Published · ppublish English Journal Article

Relation between aflatoxin, hepatitis-B virus, and hepatocellular carcinoma.

Lancet (London, England) ·Vol. 1 ·No. 8119 ·1979-04-07 ·Pages 755-7

Lutwick LI

Abstract

A new role is postulated for aflatoxin in the production of hepatocellular carcinoma. Rather than acting as a primary carcinogen, as it seems to do in animals, it is suggested that aflatoxin suppresses cell-mediated immunity. This effect on the immune system would allow the hepatitis-B virus, highly endemic in certain populations, to maintain itself more easily in the liver, to produce more chronic infection and cirrhosis, and in the long term to lead to a high incidence of hepatocellular carcinoma.

MeSH Terms
Aflatoxins/adverse effects,immunology Carcinogens Carcinoma, Hepatocellular/etiology Carrier State/immunology Chronic Disease Hepatitis B/immunology,microbiology Hepatitis B virus/immunology Humans Immune Tolerance Immunity, Cellular Immunologic Deficiency Syndromes/complications Liver/microbiology Liver Neoplasms/etiology Male
Chemicals
Aflatoxins Carcinogens
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Lutwick L I
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1979-04-07
Pages
755-7
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]